Indian billionaires bet big on head start in coronavirus vaccine race - The Boston Globe

Indian billionaires bet big on head start in coronavirus vaccine race - The Boston Globe: The Serum Institute of India is doing what few other companies in the race for a vaccine are doing: mass-producing hundreds of millions of doses of a vaccine candidate that is still in trials and might not even work. But if it does, Adar Poonawalla, Serum’s chief executive, will become one of the most tugged-at men in the world. He will have on hand what everyone wants, possibly in greater quantities before anyone else.